Suppression by sodium, potassium or nucleotides of binding between cardiac steroid (digoxigenin) and sodium- and potassium-dependent adenosine triphosphatase formed in the presence of magnesium and phosphate.
D000255:Adenosine Triphosphate / Q000031:analogs & derivatives / Q000494:pharmacology; D000818:Animals; D002417:Cattle; D004076:Digoxigenin / Q000378:metabolism*; D004077:Digoxin / Q000031:analogs & derivatives*; D066298:In Vitro Techniques; D007700:Kinetics; D008274:Magnesium / Q000494:pharmacology; D009711:Nucleotides / Q000494:pharmacology*; D010042:Ouabain / Q000378:metabolism; D010710:Phosphates / Q000494:pharmacology; D011188:Potassium / Q000494:pharmacology*; D011485:Protein Binding / Q000187:drug effects; D012964:Sodium / Q000494:pharmacology*; D000254:Sodium-Potassium-Exchanging ATPase / Q000378:metabolism*
D009711:Nucleotides; D010710:Phosphates; D010042:Ouabain; D004077:Digoxin; D000255:Adenosine Triphosphate; D012964:Sodium; D000254:Sodium-Potassium-Exchanging ATPase; D008274:Magnesium; D004076:Digoxigenin; D011188:Potassium